Kulicke and Soffa Industries, Inc. — Q1 Fiscal 2023 Form 10-Q Summary
Business context and reporting period
The filing covers the three months ended December 31, 2022, compared with the three months ended January 1, 2022. The company designs, manufactures and sells semiconductor assembly equipment, tools, aftermarket products and services. Reportable segments are Capital Equipment and Aftermarket Products and Services (APS).
The company operates in a cyclical and seasonal semiconductor capital-equipment market. Management cited lower customer investment, reduced semiconductor utilization, macroeconomic uncertainty, supply-chain constraints, inflationary pressures, geopolitical risks and continuing COVID-19-related uncertainty.
Financial performance and liquidity
| Metric | Q1 FY2023 | Q1 FY2022 | Change |
|---|---|---|---|
| Net revenue | $176.2 million | $460.9 million | Down 61.8% |
| Gross profit | $88.7 million | $223.2 million | Down 60.3% |
| Gross margin | 50.3% | 48.4% | Up 190 basis points |
| Income from operations | $11.8 million | $151.1 million | Down 92.2% |
| Operating margin | 6.7% | 32.8% | Down approximately 2,610 basis points |
| Net income | $14.6 million | $133.6 million | Down 89.1% |
| Diluted EPS | $0.25 | $2.11 | Down 88.2% |
| Operating cash flow | $85.1 million | $95.9 million | Down 11.2% |
Capital Equipment revenue declined 66.9% to $135.4 million, primarily due to lower customer investment and volume. APS revenue declined 22.0% to $40.9 million, principally because of lower volume in spares, services and bonding tools as customer utilization decreased.
Capital Equipment gross margin increased to 48.8% from 46.9% because of favorable customer and product mix. APS gross margin decreased to 55.3% from 60.4% because of less favorable product mix and pricing in bonding tools. SG&A increased 8.8% to $42.4 million, including a $6.4 million unfavorable foreign-exchange impact, while R&D increased 4.0% to $34.5 million, primarily due to higher staffing costs.
Interest income increased to $6.6 million from $0.5 million because of higher interest rates on cash and investments. The effective tax rate increased to 20.5% from 11.8%, primarily due to mandatory capitalization of R&D expenditures for foreign minimum tax purposes.
Operating cash flow was supported by a $108.8 million decrease in receivables, partly offset by a $27.2 million inventory increase and a $32.8 million decrease in accounts payable, accrued expenses and other current liabilities. Investing cash flow included $13.9 million of capital expenditures and a net $25.0 million purchase of short-term investments. Financing cash outflows included $46.3 million of share repurchases and $9.7 million of dividends.
Cash and cash equivalents were $550.6 million at December 31, 2022, and short-term investments were $245.0 million, for total cash, cash equivalents and short-term investments of $795.6 million. Total liabilities were $372.6 million and shareholders’ equity was $1.177 billion. The company had no borrowings under its $150.0 million unsecured overdraft facility; a $5.0 million bank-guarantee facility had $3.1 million outstanding.
Material changes versus the prior comparable period
- Revenue fell $284.7 million, reflecting a sharp reduction in Capital Equipment demand and lower APS utilization.
- Gross margin improved despite the revenue decline, but operating leverage deteriorated substantially as operating expenses increased while revenue contracted.
- Net income declined $119.0 million, while diluted EPS declined from $2.11 to $0.25.
- Cash flow from operations remained positive but decreased by $10.8 million.
- Inventory increased to $211.6 million from $185.0 million, primarily because of slower utilization.
- The company repurchased approximately 1.054 million shares for $45.4 million. Remaining authorization was approximately $203.8 million under an $800 million program expiring August 1, 2025.
- Quarterly dividends of $0.19 per share were declared; $9.7 million was paid during the quarter.
- Foreign currency translation and hedging adjustments produced $17.6 million of other comprehensive income, compared with a $1.0 million loss in the prior-year quarter.
Guidance, outlook, risks and unusual items
Management expects fiscal 2023 capital expenditures of approximately $70 million to $74 million, with $15.7 million incurred through the first quarter. Planned spending includes research and development, manufacturing improvements, information-technology security, enterprise-resource-planning implementation and facility leasehold improvements.
Management believes available cash, short-term investments, existing credit facilities and expected operating cash flows will be sufficient to meet liquidity and capital requirements for at least the next twelve months and beyond. Approximately $548.3 million of cash, cash equivalents and short-term investments were held by foreign subsidiaries at December 31, 2022.
Key risks include semiconductor-cycle volatility, limited demand visibility, customer concentration, China-related demand and policy risks, U.S.-China trade restrictions, Taiwan-China geopolitical tensions, supply-chain and logistics disruptions, inflation, labor shortages, foreign-exchange exposure, COVID-19 developments and potential impairment of goodwill or other assets. Approximately 89.1% of quarterly revenue was shipped outside the United States, and 32.8% was shipped to customers headquartered in China.
The company had $273.1 million of inventory purchase obligations, including $153.6 million due in fiscal 2023, and approximately $9.6 million of uncalled private-equity fund commitments. It also reported $17.0 million of unrecognized tax benefits, including accrued interest. A 10% foreign-currency fluctuation could affect financial position, results of operations or cash flows by approximately $4.0 million to $5.0 million. No material changes were reported to the prior Form 10-K risk factors, and management concluded that disclosure controls were effective.
Important facts for investors to verify
- Whether the steep Capital Equipment revenue decline represents a temporary semiconductor-cycle downturn or a more prolonged reduction in customer capital spending.
- Whether the improved consolidated gross margin can be sustained as product, customer and segment mix changes.
- Inventory levels, utilization trends and any future inventory valuation charges.
- Progress against the $70 million to $74 million fiscal 2023 capital-expenditure plan and the effect on free cash flow.
- The pace and valuation of future share repurchases relative to operating cash generation and demand conditions.
- Exposure to China, Taiwan-China tensions, export controls, tariffs and supply-chain disruptions.
- Potential changes in the 20.5% effective tax rate, unrecognized tax benefits and foreign minimum-tax effects.
- Customer concentration and the collectability of receivables, including the customer representing 25.0% of accounts receivable at December 31, 2022.